Mar 8, 2024 07:00AM

Mar 7, 2024 06:00AM

Feb 28, 2024 07:05AM

Jan 8, 2024 07:49AM

Jan 8, 2024 07:45AM

Dec 14, 2023 07:30AM

Jun 8, 2023 11:30AM Leading Proxy Advisory Firm Glass Lewis Recommends MindMed Shareholders Vote FOR All Six Company Nominees

May 25, 2023 08:00AM

May 2, 2023 08:00AM

Aug 12, 2022 07:30AM

Apr 5, 2022 07:30AM

Mar 28, 2022 07:30AM

Jan 25, 2022 07:30AM

Jan 18, 2022 07:30AM MindMed Enrolls First Participant in a Study of its Session Monitoring System

Dec 21, 2021 07:30AM

Dec 9, 2021 07:31AM

Dec 9, 2021 07:30AM

Aug 10, 2021 07:30AM

Aug 3, 2021 07:30AM

May 17, 2021 07:32AM

May 17, 2021 07:30AM MindMed Receives FDA Type C Meeting Response for Project Lucy Phase 2b Clinical Trial

May 14, 2021 07:32AM

May 13, 2021 07:30AM

May 5, 2021 07:30AM

Feb 18, 2021 07:30AM

Feb 17, 2021 07:30AM

Feb 2, 2021 07:30AM

Jan 14, 2021 07:30AM MindMed Adds Chief Development Officer with FDA Phase 2 Psilocybin Clinical Trial Experience

Dec 14, 2020 07:30AM

Nov 16, 2020 07:30AM

Oct 5, 2020 05:00AM

Jun 8, 2020 07:00AM

Jun 4, 2020 07:00AM

Apr 20, 2020 05:00AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All